Researchers have developed a tool that uses blood biomarkers to help determine when steatotic liver disease is caused by ...
A recent review highlights a promising therapeutic target for metabolic dysfunction–associated fatty liver disease (MAFLD) ...
An intelligent liver function test platform (iLFT) successfully integrated into one Scottish primary care system reduced unnecessary specialist referrals over a 5-year period, and improved triage for ...
Doctors can diagnose fatty liver disease, now called metabolic dysfunction-associated steatotic liver disease (MASLD), using blood tests that measure serum liver enzyme levels. Elevated enzyme levels ...